Shares of Nurix Therapeutics Inc. gained about 6% in premarket trading on Monday after Gilead Sciences Inc. said it exercised the option to exclusively...
Shares of Nurix Therapeutics Inc.
gained about 6% in premarket trading on Monday after Gilead Sciences Inc. said it exercised the option to exclusively license Nurix’s targeted protein degrader molecule, which is being considered as a tool to treat inflammatory conditions like rheumatoid arthritis. Per the terms, Gilead will pay $20 million upfront, with an additional $425 million in potential milestone payments. The companies first partnered in 2019, with Gilead making a $45 million upfront payment and giving Nurix the potential of $2.3 billion in additional milestones. Nurix’s stock is down 17.
gained about 6% in premarket trading on Monday after Gilead Sciences Inc. said it exercised the option to exclusively license Nurix’s targeted protein degrader molecule, which is being considered as a tool to treat inflammatory conditions like rheumatoid arthritis. Per the terms, Gilead will pay $20 million upfront, with an additional $425 million in potential milestone payments. The companies first partnered in 2019, with Gilead making a $45 million upfront payment and giving Nurix the potential of $2.3 billion in additional milestones. Nurix’s stock is down 17.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Asia Stocks Fall as Investors Digest UBS, Credit Suisse DealStock indexes across Asia fell Monday as recent turmoil weighed on bank shares
Consulte Mais informação »
Why First Republic shares went on a rollercoaster rideWhy First Republic shares went on a rollercoaster ride. The stock moved so much because there was no news about the bank over the course of the intervening hours.
Consulte Mais informação »
Zack Snyder Shares Another Image Hinting at Something Big for 'Justice League'Zack Snyder shares another image hinting at something big for 'Justice League.'
Consulte Mais informação »
Marjorie Taylor Greene shares reason she 'can't vote' for GOP budgetThe House GOP is expected to target various smaller government programs in order to slash spending in its forthcoming budget proposal.
Consulte Mais informação »
Sam Neill Shares Video About Health After Blood Cancer RevealOne day after it was revealed that he was diagnosed with stage 3 angioimmunoblastic T-cell lymphoma last year, Sam Neill took to Instagram to share a message with followers who may be worried about his health.
Consulte Mais informação »